Miguel-Angel Sanz

Author PubWeight™ 8.11^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.	Haematologica	2005	1.93
2	Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.	J Clin Oncol	2008	1.65
3	Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.	Br J Haematol	2007	1.08
4	Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.	Eur J Haematol	2006	0.88
5	Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).	Leuk Lymphoma	2003	0.87
6	Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.	Haematologica	2003	0.87
7	Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.	Biol Blood Marrow Transplant	2010	0.85